福瑞医科 (300049)
Inner Mongolia Furui Medical Science Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 26497.59
- Circulating A-Shares(W): 23350.13
- Earnings Per Share(RMB): 0.4253
- Net Assets Per Share(RMB): 7.1910
- Operating Revenue(W RMB): 110104.39
- Total Profit(W RMB): 22381.57
- Net Profit Attributable to Parent(W RMB): 11188.62
- Net Profit Growth Rate(%): 9.69
- Weighted Return on Equity(%): 6.2000
- Operating Cash Flow Per Share(RMB): 0.8030
- Undistributed Profit Per Share(RMB): 3.3233
- Capital Reserve Per Share(RMB): 3.0783
2. Main Business
The main business covers:
- Production and sales of pharmaceuticals
- Research, development and sales of diagnostic equipment
- Medical services
3. Company Basic Information
- Company Name: Inner Mongolia Furui Medical Science Co., Ltd.
- Listing Date: 2010-01-20
- Industry: Special Purpose Equipment Manufacturing
- Address: 35F, Zhonghai Plaza, No.8 Guanghua Dongli, Chaoyang District, Beijing
- Website: www.fu-rui.com
- Company Profile: The company was established through the overall restructuring of Inner Mongolia Furui Pharmaceutical Co., Ltd. On December 25, 2001, the People's Government of Inner Mongolia Autonomous Region issued document No. 65 [2001] approving the overall change of Inner Mongolia Furui Pharmaceutical Co., Ltd. into Inner Mongolia Furui Chinese and Mongolian Medicine Technology Co., Ltd. On December 26, 2001, the company was registered and established with the Inner Mongolia Autonomous Region Administration for Industry and Commerce, obtaining the Business License with registration number 1500002105375. At the time of establishment, the company's registered capital was RMB 42.54 million.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Xinyu Fuchuang Investment Co., Ltd. | General Legal Person | 904.11 | 3.87 |
| 2 | HuaBao CSI Medical ETF | Fund | 748.14 | 3.20 |
| 3 | Ruiyuan Growth Value Hybrid Securities Investment Fund Class A | Fund | 492.73 | 2.11 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 376.13 | 1.61 |
| 5 | Ping An Medical and Health Hybrid Securities Investment Fund Class A | Fund | 372.32 | 1.59 |
| 6 | Southern CSI 1000 ETF | Fund | 243.66 | 1.04 |
| 7 | Inner Mongolia Hetai Enterprise Management Co., Ltd. | General Legal Person | 222.55 | 0.95 |
| 8 | Yongying CSI Total Return Medical Devices ETF | Fund | 164.30 | 0.70 |
| 9 | Great Wall Consumption Value-added Hybrid Securities Investment Fund Class A | Fund | 100.00 | 0.43 |
| 10 | Ping An Pharmaceutical Selection Stock Securities Investment Fund Class A | Fund | 82.77 | 0.35 |
5. Concept Sectors
- Infant and Child Concept
- Intelligent Healthcare
- Big Data
- Family Doctor
- Hepatitis Concept
- Margin Trading
- ChiNext 300
- ChiNext Growth
- ChiNext Healthcare
- ChiNext 200
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information